RxDoctor Payments Data

Carol Lancaster, NP

Psychiatric/Mental Health · Lafayette, INNPI 1992280960

Payments from drug & device makers

$3,071in general payments, 2019–2025

Across 164 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$643
  • Otsuka America Pharmaceutical, Inc.$401
  • Alkermes, Inc.$336
  • Teva Pharmaceuticals USA, Inc.$332
  • Johnson & Johnson$262
  • Corium, LLC$201
  • plus $896 from 10 others

What the payments were for

  • Food & beverage$3,069100%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,071 in reported general payments places this provider in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$7,422
Medicare patients
18
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate17$40,276
VraylarCariprazine Hcl13$16,672
Lurasidone Hcl31$7,739
TrintellixVortioxetine Hydrobromide15$7,179
Desvenlafaxine Succinate ErDesvenlafaxine Succinate40$6,659
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine23$2,260
Oxcarbazepine29$993
Trazodone Hcl54$801
Duloxetine Hcl68$689
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$616
Buspirone Hcl49$598
Doxepin Hcl25$440
Olanzapine27$415
Quetiapine Fumarate31$376
Lamotrigine47$352

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$262$40,27617 claims
AbbVieVraylar$643$16,67213 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$51$7,17915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →